I agree with you, but to say that the share price isn't going...

I agree with you, but to say that the share price isn't going anywhere significant anytime soon is a bold statement that could be wrong. We have imminent readouts for PSIGAD, the possible opening of Clarion Clinics, the JP Morgan Health conference happening next week, and possible updates on 42x and 675A, not to mention everything that's being done by APIRX

I'm pretty bullish on the company and personally don't intend to sell anytime soon. However, people have every right to be frustrated with how the redomicile went, especially not having access to their shares for a +/- 3-month period. Definitely not ideal